TrialAesthetic surgery journal2020

Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.

Benjamin Ascher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.